Synonym |
Fmoc-PPP-OH |
Species |
N/A |
Protein Accession |
N/A |
Purity |
95% |
Endotoxin Level |
<1 EU/ug |
Biological Activity |
N/A |
Expression System |
N/A |
Fusion Tag |
N/A |
Predicted Molecular Mass |
473.44 Da |
Formulation |
Supplied as a lyophilized powder |
Reconstitution |
Reconstitute in water to a concentration of 1 mg/ml |
Storage & Stability |
Store at -20°C upon arrival. For long term storage, store at -20°C or -80°C |
FAQ
What is Fmoc-PPP-OH used for in peptide synthesis, and why is it important?
Fmoc-PPP-OH is a
protected form of the amino acid hydroxyproline utilized in solid-phase peptide synthesis (SPPS), which
is an essential method in the field of peptide chemistry. The compound is integral to the Fmoc-based
SPPS, where it acts as a building block for peptides incorporating the amino acid proline with a
hydroxyl functional group. This specific form of proline is noteworthy in peptide chemistry due to its
role in stabilizing the secondary structure of proteins, such as collagen, by facilitating the formation
of particular structural motifs like the polyproline helix.
One of the key advantages of using
Fmoc-PPP-OH is its contribution to the synthesis of peptides that mimic naturally occurring protein
structures. Proteins such as collagen, that are rich in hydroxyproline, play crucial roles in various
biological processes and are abundant in connective tissues. By enabling the synthesis of peptides with
precise sequences that include hydroxyproline, researchers can explore the structural and functional
properties of these proteins in a controlled laboratory setting. This capability is particularly
important for drug discovery and development, where understanding protein structure-function
relationships is critical.
Furthermore, the Fmoc (9-fluorenylmethoxycarbonyl) group in
Fmoc-PPP-OH serves as a temporary protective group for the amino functionality during SPPS. This
protection is vital as it prevents undesired side reactions, allowing for the stepwise assembly of
peptide chains in a controlled manner. The Fmoc group can be selectively removed under mild basic
conditions, a process that is readily compatible with the conditions typically used in automated peptide
synthesizers, making it a practical choice for large-scale peptide production.
By using
Fmoc-PPP-OH, researchers can effectively introduce hydroxyproline into peptides without compromising the
integrity of the other amino acids in the sequence. Its significance is underscored in the synthesis of
matrix metalloproteinase inhibitors, which are prospective therapeutic agents targeting diseases related
to excessive collagen breakdown, such as arthritis and cancer metastasis.
In summary, Fmoc-PPP-OH
is indispensable in the domain of peptide synthesis due to its capacity to incorporate a biologically
relevant modification in peptide sequences while facilitating accurate and efficient syntheses. Its role
extends beyond mere chemical utility by offering insights into the structure, function, and therapeutic
potential of crucial protein components in human biology.
Are there any specific conditions
required for handling and storing Fmoc-PPP-OH?
Handling and storing chemicals such as Fmoc-PPP-OH
necessitate adherence to specific conditions to preserve the integrity and activity of the compound over
time. First and foremost, Fmoc-PPP-OH should be stored in a dry environment, as moisture can
significantly compromise its stability. Exposure to moisture can lead to hydrolysis of the Fmoc
protecting group, resulting in the degradation of the compound and potential side reactions during
peptide synthesis. Storing the compound in a desiccator or tightly sealed container in a
humidity-controlled room or cabinet is advisable.
Temperature also plays a crucial role in the
stability of Fmoc-PPP-OH. Ideally, the compound should be stored at low temperatures, typically in the
range of -20 °C to 4 °C. This reduced temperature setting ensures that the compound remains chemically
stable and avoids decomposition over extended periods. Long-term exposure to ambient temperatures can
become problematic as it may accelerate the breakdown of sensitive chemical groups, thus compromising
the purity and effectiveness of Fmoc-PPP-OH in peptide synthesis applications.
From a handling
perspective, it is critical that individuals use appropriate personal protective equipment (PPE) such as
gloves, lab coats, and safety glasses. These safety measures help prevent direct skin contact or
inhalation, which could be harmful. Fmoc-PPP-OH should also be manipulated using standard laboratory
equipment such as chemical fume hoods to minimize the exposure to dust and vapors, also protecting the
researcher from accidental inhalation of potentially hazardous substances.
When preparing
solutions of Fmoc-PPP-OH for machining, it is important to use appropriate solvents that will not
inadvertently compromise the Fmoc protective group. Dichloromethane, dimethylformamide (DMF), or other
peptide synthesis-compatible solvents are often recommended due to their inert nature relative to the
functionalities present in Fmoc-PPP-OH. Implementing high-purity solvents reduces the risk of impurities
and side reactions which could affect peptide synthesis outcomes.
Adhering to these specific
handling and storage conditions not only extends the shelf life of Fmoc-PPP-OH, maintaining its chemical
properties for accurate peptide synthesis but also ensures safety for researchers in laboratory
settings.
How does the hydroxyl group in Fmoc-PPP-OH affect the properties of peptides
synthesized with it?
The incorporation of the hydroxyl group in peptides synthesized using
Fmoc-PPP-OH fundamentally influences the physical and chemical properties of the resulting peptides,
leading to significant impacts on their structural integrity, solubility, and biological functionality.
The hydroxyl group in hydroxyproline is a critical moiety that introduces unique characteristics to
peptides, primarily through its role in the formation and stabilization of secondary structures. In
peptides, the presence of hydroxyproline can significantly enhance the stability of collagen triple
helices. The hydroxyl groups engage in hydrogen bonding, which bolsters and stabilizes the tight packing
of the triple helix structure characteristic of collagen. This results in stronger and more resistant
protein structures, which are essential for the structural framework of various tissues, including skin,
bones, and connective tissues.
The hydroxyl group's presence can also alter the solubility
profile of peptides. Hydroxyproline-containing peptides generally exhibit enhanced solubililty in
aqueous environments compared to their non-hydroxylated counterparts. This increased solubility is
attributed to the formation of hydrogen bonds between the hydroxyl groups and water molecules,
facilitating better interaction with polar solvents. Consequently, peptides incorporating hydroxyproline
may be more amenable to aqueous formulations, which are preferable for certain biological applications
where solubility plays a critical role, such as in pharmaceuticals and as
biomaterials.
Furthermore, the addition of the hydroxyl group inherently affects the conformation
of peptides. By imposing a constrained rotational freedom on the peptide backbone, hydroxyproline leads
to the formation of unique structural motifs that are crucial for protein recognition and function. This
modulation of peptide conformation is significant in the design of peptide-based drugs and biomaterials
where specific shapes and charges are essential for functionality.
The hydroxyl group also
contributes to the immunogenic and metabolic properties of peptides. Hydroxyproline is less prone to
enzymatic degradation compared to proline, offering an enhanced metabolic stability to peptides that
include this amino acid. As such, these peptides can demonstrate prolonged biological activity and
reduced degradation in biological systems, which is an advantageous property in therapeutic applications
where controlled and sustained release is desired.
Therefore, by influencing structural
stability, solubility, conformation, and metabolic stability, the hydroxyl group in Fmoc-PPP-OH provides
vital characteristics that significantly expand the utility of peptides in research and therapeutic
contexts. These enhancements underscore the importance of hydroxyproline in producing peptides with
specialized properties tailored for particular biochemical and pharmacological applications.
What
are the potential challenges when synthesizing peptides with Fmoc-PPP-OH, and how can they be
overcome?
Synthesizing peptides with Fmoc-PPP-OH presents several challenges, largely
attributable to its highly specialized chemical structure and the conditions required for its
incorporation. Notably, the incorporation of hydroxyproline via Fmoc-PPP-OH can lead to issues such as
incomplete coupling, steric hindrance, and side reactions that complicate peptide elongation. Addressing
these challenges requires careful optimization of various parameters throughout the peptide synthesis
process.
One common issue is the incomplete coupling of Fmoc-PPP-OH during peptide chain
elongation. This may arise from steric hindrance, given the bulky nature of the Fmoc group coupled with
hydroxyproline's rigid, cyclic structure. To mitigate this, coupling efficiency can be improved by using
excess amounts of the Fmoc-PPP-OH reagent, ensuring that an adequate amount reacts with the growing
peptide chain. Additionally, employing a highly efficient coupling reagent, such as HBTU or DIC in the
presence of HOBt, can facilitate the activation and subsequent successful incorporation of the amino
acid.
Another challenge involves the side reactions that could compromise the integrity of the
peptide, considering the presence of a reactive hydroxyl group. Protecting or masking potential reactive
sites during synthesis mitigates unwanted side reactions. Preemptive measures, such as the careful
selection of solvent and conditions, play a critical role in preserving the functional integrity of the
hydroxyl group. Employing highly pure and non-reactive solvents like dichloromethane or
dimethylformamide, diminishes interference, creating conditions for stable peptide
formation.
Additionally, the protection and deprotection steps involving the Fmoc group pose
their challenges, particularly in ensuring complete removal to prevent synthesis hindrance. Oxidative
deprotection, typically executed under basic conditions, necessitates precise control of pH to avoid
undesirable reactions, such as racemization. Thus, ensuring proper deprotection involves optimizing the
base concentration and deprotection duration to achieve thorough Fmoc removal without compromising the
rest of the peptide.
Peptide solubility in aqueous environments poses yet another concern.
Strategically designing the sequence to include hydrophilic residues can aid solubility, enhancing
purification procedures such as HPLC (high-performance liquid chromatography). Additionally,
implementing modifications like cyclization or post-synthetic purification protocols helps rectify
solubility challenges and ensures the integrity of the final peptide product.
In conclusion,
while synthesizing peptides with Fmoc-PPP-OH entails addressing several complexities, meticulous
attention to reagents, reaction conditions, and strategic optimizations of synthesis processes can
effectively surmount these challenges. Engaging these strategies ensures the successful incorporation of
hydroxyproline through Fmoc-PPP-OH, realizing the advanced synthesis of functionally significant
peptides suited for diverse research and therapeutic applications.
What experimental conditions
are recommended for deprotection of Fmoc from Fmoc-PPP-OH?
The deprotection of the Fmoc group
from Fmoc-PPP-OH is a pivotal step in peptide synthesis, necessitating precise control over experimental
conditions to achieve optimal results without undermining the integrity of the peptide chain. Fmoc
deprotection typically involves mild basic conditions that selectively remove the Fmoc group while
maintaining other protective groups intact, ensuring the sequential buildup of the peptide
chain.
A commonly recommended reagent for Fmoc deprotection is piperidine, diluted in a polar
organic solvent such as dimethylformamide (DMF). Typically, a 20% (v/v) piperidine in DMF solution
provides sufficient basicity to cleave the Fmoc group efficiently without causing unnecessary stress or
damage to the peptide chain. This concentration strikes a balance between reactivity and selectivity,
ensuring effective deprotection while minimizing side reactions such as base-induced degradation or
racemization of sensitive residues.
Temperature control is critical during deprotection, as
elevated temperatures can accelerate the reaction but may also increase the risk of side reactions. Room
temperature (approximately 20-25 °C) is generally ideal, permitting efficient Fmoc cleavage without
unnecessary thermal stress on the peptide. The reaction is usually carried out for a duration of 20-30
minutes, though this may vary slightly based on the specific peptide sequence and the presence of other
functional groups in the chain.
Another key consideration is maintaining an inert atmosphere
during deprotection, protecting the peptide from atmospheric moisture and oxygen that could interfere
with the reaction. Conducting the process under a nitrogen or argon flush is advisable, particularly in
cases where sensitive sequences or residues are involved, reducing the risk of oxidation or other
unwanted side reactions.
Moreover, ensuring thorough washing and removal of piperidine and the
dibenzofulvene byproduct after the deprotection step is paramount. This is typically achieved by
multiple rinses with DMF or another appropriate solvent, preventing residual basicity from affecting
subsequent coupling or causing the degradation of the synthesized peptide.
Post-deprotection, it
can be beneficial to neutralize the reaction environment through washing with acetic acid or a similar
mild acid to reset the reaction vessel and peptide chain to neutral conditions, preparing them optimally
for subsequent synthesis steps.
In summary, the successful deprotection of Fmoc from Fmoc-PPP-OH
hinges on meticulously controlled experimental conditions—utilizing appropriate concentrations of
piperidine in DMF at ambient temperature, ensuring an inert atmosphere, and conducting thorough
post-reaction washes. Adhering to these guidelines ensures clean and efficient removal of the Fmoc
group, facilitating the accurate extension of peptide chains during synthesis.